Asthma and allergies strike 1 of 5 Americans, making it the most prevalent chronic disease, ranking higher than cancer, diabetes and heart disease. In fact, because more than 50 million Americans suffer from allergies it’s one of the leading causes of missed school and work.
This chronic disease has heavy cost implications to society. Allergies have an annual economic impact of $12.3 billion – $14.5 billion on direct care and $2.2 billion on indirect costs related primarily to lost work productivity.
Compounding the problem is a looming shortage of allergists in the United States; expected to decline 6.8% by 2020. Demand for allergists over the same period is expected to increase by 35%. Therefore the treatment of allergy sufferers falls to primary care providers.
Through the routine care of immunotherapy, healthcare costs can be reduced by 33%-41% in as little as 18 months. But currently, only 2-3% of patients that need IT actually receive it.
United Allergy Services (UAS) exists to empower providers and advance the understanding of immunotherapy (IT) as the only known disease-modifying treatment for allergies. We bring effective and convenient allergy testing and immunotherapy to primary care providers and others that treat the vast majority of patients with seasonal and perennial allergies.
UAS Clinical Allergy Technicians/Specialists (CAT/CAS) work under the provider’s direct supervision to test, analyze and perform dilutions for immunotherapy treatments.
UAS works with more than 2,600 practitioners across 25 states. More than 10 million allergy tests have been conducted and 14 million IT treatments have been administered. IT is a proven, safe treatment and UAS has treated 115,000 patients (34 million injections).